Implantation failure and early pregnancy loss affect millions of couples each year. We're building the tools to understand why—and to help.
Recurrent implantation failure (RIF) leaves couples without answers. After multiple IVF cycles with good-quality embryos, the question remains: why isn't this working?
The endometrium holds the key. By understanding the biological state of the uterus—its immune environment, vascular readiness, and tissue architecture—we can identify what's preventing implantation and design targeted interventions.
of IVF patients experience recurrent implantation failure
of couples affected globally each year
Without mechanistic insight, treatment remains trial-and-error. Our platform enables precision diagnosis of endometrial dysfunction.
The first trimester isn't just about implantation—it's about building the placenta that will sustain the entire pregnancy. When trophoblast invasion is impaired or placental development goes awry, the consequences ripple through the remaining months.
Poor placentation in the first trimester drives preeclampsia, fetal growth restriction, and preterm birth. These aren't separate diseases—they're manifestations of the same underlying problem: inadequate placental function established in the earliest weeks.
of pregnancies develop preeclampsia, a leading cause of maternal morbidity
of pregnancies are affected by fetal growth restriction
of pregnancies end in miscarriage, often due to placental dysfunction
We start with implantation—a tractable entry point for mechanistic discovery. As our platform matures and we build deeper biological understanding, we expand into miscarriage and broader early pregnancy outcomes. Every patient we help understand their implantation biology moves us closer to solving early pregnancy loss.
How our platform works